FOI release

Freedom of Information responses from the MHRA - week commencing 1 February 2021

Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 1 February 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 24 March 2021

Documents

Freedom of Information request to Medicines and Healthcare products Regulatory Agency (FOI-20-566)

HTML

Freedom of information request on Covid-19 vaccine Immune enhancement diseases (FOI-21-001)

HTML

Freedom of Information request on Ethigen Inspection reports 2017 (FOI 21/003)

HTML

GDP Inspection Report 1 (FOI-21-003)

PDF, 2.56 MB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

GDP Inspection Report 2 (FOI-21-003)

PDF, 1.97 MB, 8 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on Yellow Card reports of Covid-19 vaccine side-effects (FOI-21-004)

HTML

Freedom of Information request on COVID 19 Vaccine Adverse Reaction Information (FOI-21-005)

HTML

Freedom of Information request about Covid vaccine safety (FOI-21-007)

HTML

Freedom of Information request for information: Exjade (Deferasirox) (FOI-21-011)

HTML

Annex 4 - Specific adverse drug reaction follow up forms (FOI-21-011)

PDF, 650 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Lacosamide Additional Information (FOI-21-011)

PDF, 107 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about adverse reactions to Pfizer/BioNTech Covid-19 vaccine (FOI-21-012)

HTML

Freedom of Information request about Covid vaccine adverse events (FOI-21-013)

HTML

Freedom of Information request about COVID19 Vaccine Adverse Reaction Data (FOI-21-015)

HTML

Freedom of Information request about all Pharmacovigilance inspection reports from Jan 2020 to Dec 2020 (FOI-21-016)

HTML

Pharmacovigilance inspection reports 1 (FOI-21-16)

PDF, 3.08 MB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 2 (FOI-21-16)

PDF, 2.85 MB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 3 (FOI-21-16)

PDF, 311 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 4 (FOI-21-16)

PDF, 4.65 MB, 31 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 5 (FOI-21-16)

PDF, 3.54 MB, 57 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 6 (FOI-21-16)

PDF, 2.71 MB, 12 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance inspection reports 7 (FOI-21-16)

PDF, 3.33 MB, 46 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about number of Pfizer/BioNTech vaccine vials discarded, lost, or stolen since MHRA approval (FOI-21-017)

HTML

Freedom of Information request about adverse drug reactions (ADR) to Covid-19 vaccines (FOI-21-018)

HTML

Freedom of Information request about yellow card reports for Covid Vaccines (FOI-21-023)

HTML

Freedom of Information request about information relating to Dioctyl 100 mg Capsules (PL00039/0737) (FOI-21-026)

HTML

Dioctyl pre-clinical and clinical expert report (FOI-21-026)

PDF, 479 KB, 10 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about adverse Reactions to the Coronavirus vaccines (FOI-21-029)

HTML

Freedom of Information request about number of benzodiazepines seized by MHRA (FOI-21-030)

HTML

Freedom of Information request about the Origination of Biotechnology, Biotechnology Companies and Vaccines (FOI-21-035)

HTML

Freedom of Information request about the Origination of Biotechnology, Biotechnology Companies and Vaccines, COVID19 Vaccine information (FOI-21-044 to FOI-21-048)

HTML

Freedom of Information request about COVID19 Vaccine Adverse Reaction Data (FOI-21-049)

HTML

Freedom of Information request about Covid-19 Vaccine Adverse Events and Deaths (FOI-21-054)

HTML

Freedom of Information request about LifeVac, Dechoker (FOI-21-055 )

HTML

Freedom of Information request about Yellow Card scheme statistics (FOI-21-056)

HTML

Freedom of Information request about Adenocor PL 04425/0159 (FOI-21-066)

HTML

Application for product licence (FOI-21-066)

PDF, 1.18 MB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about Pfizer biotech COVID-19 mRNA Vaccine BNT162b2 , COVID-19 Vaccine AstraZeneca adverse effects (FOI-21-067)

HTML

Freedom of Information request about assessment reports for the medicinal products Adenocor 3mg/ml Solution for injection (PL 11723/0005) and Adenoscan 30 mg/10 ml, solution for infusion (PL 11723/0086) (FOI-21-069)

HTML

Assessment Report 1 (FOI-21-069)

PDF, 1.18 MB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Assessment Report 2 (FOI-21-069)

PDF, 929 KB, 15 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about deaths, injuries and adverse effects from the Covid-19 vaccine (FOI-21-072)

HTML

Freedom of Information request about COVID19 Vaccine Adverse Reaction Data, Hospitalisations, Deaths (FOI-21-078)

HTML

Freedom of Information request about Adverse reactions regarding Covid-19 vaccines (FOI-21-080)

HTML

Freedom of Information request: enquiry about CPRD and Pneumococcal Disease Data, 2018, 2019, 2020 (FOI-21-107)

HTML

Details

See the MHRA FOI disclosure log.

See all FOI responses from the MHRA for 2021.

Published 24 March 2021